[HTML][HTML] Therapeutic potential of nanotechnology-based approaches in osteoarthritis

L Xiao, J Cui, Z Sun, Y Liu, J Zheng… - Frontiers in …, 2022 - frontiersin.org
Osteoarthritis (OA) is a multifactorial disease that affects the entire joint, often resulting in
severe pain, disability, psychological distress, and a lower quality of life. Patient self …

Nanomedicine and regenerative medicine approaches in osteoarthritis therapy

R Goudarzi, AR Dehpour, A Partoazar - Aging Clinical and Experimental …, 2022 - Springer
Osteoarthritis (OA), the most common chronic joint disease, is a degenerative disease that
affects 7% of the worldwide population, more than 500 million people all over the world. OA …

[HTML][HTML] Recent advances in nano-therapeutic strategies for osteoarthritis

X Guo, J Lou, F Wang, D Fan, Z Qin - Frontiers in Pharmacology, 2022 - frontiersin.org
Osteoarthritis (OA) is the most common type of arthritis and the leading cause of disability
globally. It tends to occur in middle age or due to an injury or obesity. OA occurs with the …

[HTML][HTML] Development of nanomaterials to target articular cartilage for osteoarthritis therapy

C Rao, S Shi - Frontiers in Molecular Biosciences, 2022 - frontiersin.org
Osteoarthritis (OA) is an obstinate, degradative, and complicated disease that has drawn
much attention worldwide. Characterized by its stubborn symptoms and various sequela, OA …

Nanoparticle‐Based Drug Delivery System—A Target Strategy for Osteoarthritis Treatment

K Liu, D Zhang, W Wang - Journal of Nanomaterials, 2021 - Wiley Online Library
Osteoarthritis (OA) is a bone and joint disease with pathological characteristics such as
articular cartilage degeneration injury and synovial and subchondral bone reactive …

Nanotechnology and Osteoarthritis. Part 2: Opportunities for advanced devices and therapeutics

TB Lawson, JTA Mäkelä, T Klein… - Journal of …, 2021 - Wiley Online Library
Osteoarthritis (OA) is a multifactorial disease of the entire joint which afflicts 140 million
individuals worldwide regardless of economic or social status. Current clinical treatments for …

New insights in osteoarthritis diagnosis and treatment: Nano‐strategies for an improved disease management

M Paesa, T Alejo, F Garcia‐Alvarez… - Wiley …, 2023 - Wiley Online Library
Osteoarthritis (OA) is a common chronic joint pathology that has become a predominant
cause of disability worldwide. Even though the origin and evolution of OA rely on different …

Nanotechnology-boosted biomaterials for osteoarthritis treatment: current status and future perspectives

L Liu, H Tang, Y Wang - International Journal of Nanomedicine, 2023 - Taylor & Francis
Osteoarthritis (OA) is a prevalent global health concern, posing a significant and increasing
public health challenge worldwide. Recently, nanotechnology-boosted biomaterials have …

Management of osteoarthritis: From drug molecules to nano/micromedicines

M Di Francesco, A Fragassi… - Wiley …, 2022 - Wiley Online Library
With the change in lifestyle and aging of the population, osteoarthritis (OA) is emerging as a
major medical burden globally. OA is a chronic inflammatory and degenerative disease …

[HTML][HTML] Microenvironment-Responsive Nanosystems for Osteoarthritis Therapy

S Li, Y Xiong, H Zhu, T Ma, X Sun, J Xiao - Engineered Regeneration, 2023 - Elsevier
Osteoarthritis (OA) represents an enduring and widespread global burden, causing
significant morbidity and disability, whose pathology is characterized by persistent …